| 移植物抗宿主病生物学标志物的研究进展 |
| |
| 引用本文： | 孔庆玲,陈伟,徐开林.移植物抗宿主病生物学标志物的研究进展[J].国际输血及血液学杂志,2017,40(3). |
| |
| 作者姓名： | 孔庆玲 陈伟 徐开林 |
| |
| 作者单位： | 221002,江苏徐州医学院附属医院血液科 |
| |
| 基金项目： | 江苏省卫生国际交流支撑计划基金项目(JSH-2017-008)Jiangsu Provincial Health International Exchange Support Fund |
| |
| 摘 要： | 异基因造血干细胞移植(allo-HSCT)是某些血液系统肿瘤和部分自身免疫缺陷性疾病唯一有效的治疗手段.然而,移植物抗宿主病(GVHD)是allo-HSCT后最常见并发症之一,也是移植相关死亡的主要原因之一.目前,临床尚缺乏有效预测allo-HSCT后发生GVHD的生物学标志物.笔者从主要组织相容性复合物(MHC)、非人类白细胞抗原(HLA)基因多态性、微小RNA(MiRNA)、细胞生物学标志物、细胞因子、病理学标志物方面,对可能作为预测GVHD发生的生物学标志物进行综述.
|
| 关 键 词： | 移植物抗宿主病 造血干细胞移植 生物标志物 |
Research progress in biomarkers of graft versus host disease |
| |
| Kong Qingling,Chen Wei,Xu Kailin.Research progress in biomarkers of graft versus host disease[J].International Journal of Blood Tranfusion and Hematology,2017,40(3). |
| |
| Authors: | Kong Qingling Chen Wei Xu Kailin |
| |
| Abstract: | Allogeneic hematopoietic stem cell transplantation(allo-HSCT) is the unique effective treatment of certain hematological malignancies and partly autoimmune deficiency diseases.However,graftversus-host disease (GVHD) is one of the common complications after allo-HSCT,and is one of the main causes of death related to transplantation.Currently,we are lack of the effective biomarkers for forecasting GVHD in clinical.So this paper reviews the potential biomarkers that may be used to predict GVHD,which including major histocompatibility complex (MHC),non-human leukocyte antigen (HLA) gene polymorphism,microRNA (MiRNA),cell biology markers,cytokines,pathology markers. |
| |
| Keywords: | Graft vs host disease Hematopoietic stem cell transplantation Biomarker |
| 本文献已被 万方数据 等数据库收录！ |
|
